Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Aug 1;2(8):a009365.
doi: 10.1101/cshperspect.a009365.

Programmed cell death in Parkinson's disease

Katerina Venderova  1 , David S Park
Affiliations
Review

Programmed cell death in Parkinson's disease

Katerina Venderova et al. Cold Spring Harb Perspect Med. .

Abstract

Parkinson's disease is a debilitating disorder characterized by a progressive loss of dopaminergic neurons caused by programmed cell death. The aim of this review is to provide an up-to-date summary of the major programmed cell death pathways as they relate to PD. For a long time, programmed cell death has been synonymous with apoptosis but there now is evidence that other types of programmed cell death exist, such as autophagic cell death or programmed necrosis, and that these types of cell death are relevant to PD. The pathways and signals covered here include namely the death receptors, BCL-2 family, caspases, calpains, cdk5, p53, PARP-1, autophagy, mitophagy, mitochondrial fragmentation, and parthanatos. The review will present evidence from postmortem PD studies, toxin-induced models (especially MPTP/MPP+, 6-hydroxydopamine and rotenone), and from α-synuclein, LRRK2, Parkin, DJ-1, and PINK1 genetic models of PD, both in vitro and in vivo.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alegre-Abarrategui J, Christian H, Lufino MM, Mutihac R, Venda LL, Ansorge O, Wade-Martins R 2009. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 18: 4022–4034 - PMC - PubMed
    1. Alegre-Abarrategui J, Wade-Martins R 2009. Parkinson disease, LRRK2 and the endocytic-autophagic pathway. Autophagy 5: 1208–1210 - PubMed
    1. Alves Da Costa C, Paitel E, Vincent B, Checler F 2002. α-synuclein lowers p53–dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease. J Biol Chem 277: 50980–50984 - PubMed
    1. Andrabi SA, Dawson TM, Dawson VL 2008. p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Ann NY Acad Sci 1147: 233–241 - PubMed
    1. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y 1997. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12: 25–31 - PubMed

MeSH terms